期刊文献+

哌拉西林/三唑巴坦对临床常见致病菌的体外抑菌效果 被引量:1

In Vitro Bacteriostatic Effects of Piperacillin/tazobactam on Pathogenic Bacteria Commonly Encountered in the Clinic
下载PDF
导出
摘要 目的观察哌拉西林/三唑巴坦对临床常见致病菌的体外抑菌活性,比较国产与进口哌拉西林/三唑巴坦的体外抑菌效果。方法将336株实验菌株分别制成菌液,质控菌株为大肠埃希菌25922和铜绿假单胞菌27853。采用琼脂二倍稀释法测定各种药物的体外抑菌效果,并根据抗生素药物敏感的临界浓度计算细菌对药物的敏感率。结果国产哌拉西林/三唑巴坦对肺炎克雷白菌[超广谱β-内酰胺酶阳性(ESBLs+)]、肺炎克雷白菌(ESBLs-)、大肠埃希菌(ESBLs+)、大肠埃希菌(ESBLs-)有良好的抑菌作用,对铜绿假单胞菌的抑菌效果亦较好。与头孢哌酮/舒巴坦、头孢噻肟/舒巴坦、阿莫西林/克拉维酸钾和氨苄西林/舒巴坦等药物相比,哌拉西林/三唑巴坦体外抑菌效果最好。肠杆菌科细菌对国产与进口哌拉西林/三唑巴坦的敏感率几乎无差异,国产与进口哌拉西林/三唑巴坦对铜绿假单胞菌的抑菌效果相当。结论哌拉西林/三唑巴坦具有较强的抑菌作用,国产与进口哌拉西林/三唑巴坦的体外抑菌效果相当。 Objective To survey and compare the in vitro bacteriostatic effects of domestic and imported piperacillin/ tazobactam on Pathogenic bacteria commonly encountered in the clinic. Methods Bacterial suspensions were separately prepared for each of the 336 strains of bacteria to be tested. Escherichia coli 25922 and Pseudomonas aeruginosa 27853 surved as the quality control bacteria strains. The in vitro bacteriostatic effects of various drugs were assayed with the doubled agar dilution method. Sensitivity of bacteria to drugs was calculated according to the marginal antibiotics' concentration to which the bacteria were sensitive. Results Domestic piperacillin/tazobactam was shown to have excellent baeteriostatie effects on Klebsiella pneumoniae I super broad spectrum β-lactamase positive ( ESBLs + ), K. pneumoniae( ESBLs-), E. coli( ESBLs + ), E. coli (ESBLs-) and a fairly good inhibitory effect on P. aeruginosa. Piperacillin/tazobactam was also shown to have the best in vitro bacteriostatic effects as compared with those of cefoperazone/sulbactam ( CFP/SUB ), cefotaxime/sulbactam ( CTX/SUB ), amoxicillin/clavulaniate potassium ( AMO/CLK ), and ampicillin/sulbactam ( AMP/SUB ). Besides, the enterobacteriaceae manifested almost the same sensitivity to domestic and imported piperacillin/tazobactam and the 2 kinds of the drug showed equivalent bacteriostatic effects on P. aerllginosa. Conclusion Piperacillin/tazobactam was shown to have excellent in vitro bacteriostatic effects and domestic and imported products of the drug were comparable in this respect.
出处 《医药导报》 CAS 2006年第2期156-158,共3页 Herald of Medicine
关键词 哌拉西林/三唑巴坦 抑菌作用 体外 最小抑菌浓度 Piperacillin/tazobactam Bacteriostatic effect, in vitro Minimal inhibitory concentration (MIC)
  • 相关文献

参考文献6

二级参考文献28

  • 1朱德妹,张婴元,王宇倩,周乐,吴卫红,汪复.β-内酰胺类抗生素与β-内酰胺酶抑制剂复方制剂的体外抗菌作用[J].中国抗生素杂志,1996,21(3):198-202. 被引量:24
  • 2[1]Libermore DM. Determinants of the activity of β-lactamase inhibitor combinations. J Antimicrob Chemother, 1993, 31 (Suppl A):9 被引量:1
  • 3[2]Jones RN, Pfaller MA,Doern GV, et al. Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs:a 1997 surveillance trial in 102 medical centers in the United States. Diagn Microbiol Inect Dis,1998,30:215 被引量:1
  • 4[3]Pfaller MA,Jones RN,Doern GV,et al. Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Veneauela using the E test method. Diagn Microbiol Infect Dis,1998,30:45 被引量:1
  • 5[4]Marshall SA,Aldridge KE, Allen SD, et al. Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis, 1995,21:153 被引量:1
  • 6[5]Klepser ME,Marangos MN ,Zhuz, et al. Comparation of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococus faecalis, Escherichia coli, and Pseudomonas aeruginosa. Antimicrob Agents Chemother, 1997,41:435 被引量:1
  • 7[6]Shales DM, Norden C. Piperacillin-tazobactam compared to ticarcillin-clavulanate in community-acquired bacterial lower respiratory tract infection. 33rd ICAAC,New orleans, Louisianna, USA1993,Abstract 646 被引量:1
  • 8[7]Tan JS,Wishnow RM,Talan DA, et al. Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind ,randomized ,multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. Antimicro Agent Chemothe, 1993,37:1580 被引量:1
  • 9[8]Comerra A, Zinner S, Bock R, et al. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother, 1995,39:445 被引量:1
  • 10Pena A,Derendorf H. Pharmaeokinetic properties of beta-lactamase inhibitors[J ]. Int J Clin Pharmacol Ther ,1999,37(2) :63 - 75. 被引量:1

共引文献34

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部